Challenges faced by people with epilepsy on ketogenic diet therapy and their caregivers during the COVID-19 pandemic in Brazil

BACKGROUND: Although ketogenic diet therapy (KDT) is a well-established, nonpharmacologic therapeutic option for patients with pharmacoresistant epilepsy, its availability is still not widespread. The COVID-19 pandemic may have further restricted the access of people with pharmacoresistant epilepsy...

Descripción completa

Detalles Bibliográficos
Autores principales: Alencastro Veiga Domingues Carneiro, Raquel, dos Santos Lunardi, Mariana, Matheus Uberna Giacomini, Felipe, Kurrle Rieger, Débora, Dubois Moreira, Júlia, Carina Ribeiro da Silva, Letícia, Pereira Brito Sampaio, Leticia, Lin, Katia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761294/
https://www.ncbi.nlm.nih.gov/pubmed/34256342
http://dx.doi.org/10.1016/j.yebeh.2021.108193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761294/
https://www.ncbi.nlm.nih.gov/pubmed/34256342
http://dx.doi.org/10.1016/j.yebeh.2021.108193

Ejemplares similares